These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 11230007)

  • 41. Quetiapine-related tardive dyskinesia.
    Ghaemi SN; Ko JY
    Am J Psychiatry; 2001 Oct; 158(10):1737. PubMed ID: 11579018
    [No Abstract]   [Full Text] [Related]  

  • 42. Quetiapine: a new atypical antipsychotic for the treatment of schizophrenia.
    Gray R
    Ment Health Care; 1998 Jan; 1(5):163-4. PubMed ID: 9791402
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Use of quetiapine in children and adolescents.
    Masi G; Milone A; Veltri S; Iuliano R; Pfanner C; Pisano S
    Paediatr Drugs; 2015 Apr; 17(2):125-40. PubMed ID: 25686575
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Re: Neuroleptic malignant syndrome associated with quetiapine.
    Karagianis J; Phillips L; Hogan K; LeDrew K
    Can J Psychiatry; 2001 May; 46(4):370-1. PubMed ID: 11387795
    [No Abstract]   [Full Text] [Related]  

  • 45. Seroquel: a putative atypical antipsychotic drug with serotonin- and dopamine-receptor antagonist properties. Preclinical and early clinical trials in schizophrenia.
    J Clin Psychiatry; 1995 Sep; 56(9):438-45. PubMed ID: 7665549
    [No Abstract]   [Full Text] [Related]  

  • 46. Antipsychotic-associated weight gain and clinical outcome parameters.
    Blin O; Micallef J
    J Clin Psychiatry; 2001; 62 Suppl 7():11-21. PubMed ID: 11346191
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A case of depersonalization-derealization syndrome during treatment with quetiapine.
    Sarkar J; Jones N; Sullivan G
    J Psychopharmacol; 2001 Sep; 15(3):209-11. PubMed ID: 11565631
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clarification of anticholinergic effects of quetiapine.
    Goldstein JM; Brecher M
    J Clin Psychiatry; 2000 Sep; 61(9):680. PubMed ID: 11030492
    [No Abstract]   [Full Text] [Related]  

  • 49. Myocarditis with quetiapine.
    Roesch-Ely D; Van Einsiedel R; Kathöfer S; Schwaninger M; Weisbrod M
    Am J Psychiatry; 2002 Sep; 159(9):1607-8. PubMed ID: 12202290
    [No Abstract]   [Full Text] [Related]  

  • 50. Quetiapine and leukopenia.
    Clark N; Weissberg E; Noel J
    Am J Psychiatry; 2001 May; 158(5):817-8. PubMed ID: 11329413
    [No Abstract]   [Full Text] [Related]  

  • 51. Discontinuation of quetiapine from an NIMH-funded trial due to serious adverse events.
    Jeste DV; Jin H; Golshan S; Mudaliar S; Glorioso D; Fellows I; Kraemer H; Arndt S
    Am J Psychiatry; 2009 Aug; 166(8):937-8. PubMed ID: 19651757
    [No Abstract]   [Full Text] [Related]  

  • 52. What's in a name?
    Damodoran SS
    Aust N Z J Psychiatry; 2000 Aug; 34(4):698-9. PubMed ID: 10954408
    [No Abstract]   [Full Text] [Related]  

  • 53. Quetiapine: efficacy, tolerability and safety in schizophrenia.
    Miodownik C; Lerner V
    Expert Rev Neurother; 2006 Jul; 6(7):983-92. PubMed ID: 16831113
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Thrombocytopenia secondary to the use of quetiapine.
    Handoo I; Perales M; Klaus N; Khan AY
    J Child Adolesc Psychopharmacol; 2010 Oct; 20(5):453-5. PubMed ID: 20973718
    [No Abstract]   [Full Text] [Related]  

  • 55. Antipsychotic-associated weight gain.
    Gentile S
    Ann Pharmacother; 2004 May; 38(5):903-4. PubMed ID: 14996995
    [No Abstract]   [Full Text] [Related]  

  • 56. [Switching to quetiapine fumarate monotherapy for treatment-resistant schizophrenia: a report of five cases].
    Sánchez-Araña Moreno T; Ruiz-Doblado S; Elorza-Guisasola J; Valmisa-Gómez de Lara E
    Actas Esp Psiquiatr; 2011; 39(5):336-8. PubMed ID: 21953364
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Quetiapine addiction?
    Pinta ER; Taylor RE
    Am J Psychiatry; 2007 Jan; 164(1):174-5. PubMed ID: 17202569
    [No Abstract]   [Full Text] [Related]  

  • 58. Nizatidine for the treatment of patients with quetiapine-induced weight gain.
    Atmaca M; Kuloglu M; Tezcan E; Ustundag B; Kilic N
    Hum Psychopharmacol; 2004 Jan; 19(1):37-40. PubMed ID: 14716710
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Delusions associated with quetiapine-related weight redistribution.
    Wirshing DA; Boyd JA; Pierre JM; Saunders CS; Wirshing WC; Azizian K; Patel KR; Ashcraft JC; Darmandjian H; Feusner J
    J Clin Psychiatry; 2002 Mar; 63(3):247-8. PubMed ID: 11926726
    [No Abstract]   [Full Text] [Related]  

  • 60. FDA panel issues mixed decision on quetiapine in depression and anxiety.
    Kuehn BM
    JAMA; 2009 May; 301(20):2081-2. PubMed ID: 19470978
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.